Combinatorial interventions inhibit TGFβ-driven epithelial-to-mesenchymal transition and support hybrid cellular

Steven Nathaniel Steinway1, Jorge Gomez Tejeda Zañudo2, Paul J Michel3

  • 1Penn State Hershey Cancer Institute, Penn State College of Medicine, Hershey, PA, USA.

Insights

Combinatorial therapies targeting key feedback loops and SMAD complexes effectively suppress transforming growth factor beta (TGFβ)-driven epithelial-to-mesenchymal transition (EMT) in hepatocellular carcinoma (HCC). This approach is crucial for fully inhibiting cancer cell invasion and metastasis.

Area of Science:

  • Cancer Biology
  • Systems Biology
  • Molecular Oncology

Background:

  • Epithelial-to-mesenchymal transition (EMT) drives cancer cell invasion and metastasis, a process often hijacked from development.
  • Transforming growth factor beta (TGFβ) signaling is a key inducer of EMT and is frequently dysregulated in hepatocellular carcinoma (HCC).
  • Loss of E-cadherin expression is a hallmark of EMT, correlating with increased cancer cell invasiveness.

Purpose of the Study:

  • To identify network perturbations that can suppress TGFβ-driven EMT in cancer cells.
  • To understand the mechanisms by which combinatorial interventions inhibit cancer cell invasion.
  • To validate computational predictions through experimental testing.

Main Methods:

  • Development and application of a systems-level Boolean dynamic model of EMT.
  • Systematic screening of individual and combination perturbations using a network control approach.
  • Experimental validation using siRNA in HCC cell lines and assessment of E-cadherin expression and cell migration.

Main Results:

  • Computational models predicted that combined targeting of feedback loops and SMAD complexes is more effective than targeting SMAD alone.
  • Experimental validation confirmed that many predicted combinatorial targeting strategies significantly suppress TGFβ-driven EMT.
  • Observed that some interventions result in hybrid epithelial-mesenchymal states, which may retain invasive properties.

Conclusions:

  • EMT is driven by an interconnected signaling network, necessitating combinatorial therapies for complete suppression of invasive properties.
  • Single interventions may lead to intermediate or partial EMT states, underscoring the need for multi-target strategies.
  • Combined targeting approaches are essential to fully inhibit the invasive potential of tumor cells by overcoming resistance mechanisms.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
9.8K
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
2.4K